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DNA interstrand crosslinks (ICLs) are covalent link-
ages between two strands of DNA, and their pres-
ence interferes with essential metabolic processes
such as transcription and replication. These lesions
are extremely toxic, and their repair is essential for ge-
nome stability and cell survival. In this review, we will
discuss how the removal of ICLs requires interplay
between multiple genome maintenance pathways
and can occur in the absence of replication (replica-
tion-independent ICL repair) or during S phase (repli-
cation-coupled ICL repair), the latter being the pre-
dominant pathway used in mammalian cells. It is now
well recognized that translesion DNA synthesis (TLS),
especially through the activities of REV1 and DNA po-
lymerase zeta (Polf), is necessary for both ICL repair
pathways operating throughout the cell cycle. Recent
studies suggest that the convergence of two replica-
tion forks upon an ICL initiates a cascade of events
including unhooking of the lesion through the actions
of structure-specific endonucleases, thereby creating a
DNA double-stranded break (DSB). TLS across the
unhooked lesion is necessary for restoring the sister
chromatid before homologous recombination repair.
Biochemical and genetic studies implicate REV1 and
Polf as being essential for performing lesion bypass
across the unhooked crosslink, and this step appears
to be important for subsequent events to repair the
intermediate DSB. The potential role of Fanconi
anemia pathway in the regulation of REV1 and
Polf-dependent TLS and the involvement of additional
polymerases, including DNA polymerases kappa, nu,
and theta, in the repair of ICLs is also discussed in this
review. Environ. Mol. Mutagen. 53:725–740,
2012. VC 2012Wiley Periodicals, Inc.
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INTRODUCTION
Interstrand crosslinks (ICLs) are formed when bifunc-
tional electrophilic agents react with two bases on oppos-
ing strands of the DNA helix. This covalent linkage
imposes an insurmountable block to essential DNA meta-
bolic processes such as transcription and replication. The
repair of these lesions is essential for cell survival.
Because ICLs are so potent in blocking DNA replication,
agents that form these lesions are frequently used to treat
patients with cancer (e.g., mitomycin C, nitrogen mus-
tards, and platinum-containing compounds like cisplatin),
as well as autoimmune diseases, the latter taking advant-
age of the immunosuppressive activity of these agents
(e.g., cyclophosphamide). Therefore, understanding how
cells resist these lesions is important to our ability to
improve the therapeutic use of these drugs in the future
of personalized medicine and targeted therapy as well as
understand variations in patient response and toxicity
[Deans and West, 2011].
The formation of an ICL by these agents is a relatively
rare event when compared with the frequency of cross-
linking two adjacent bases within the same strand of
DNA (i.e., an intrastrand crosslink). The more prevalent
intrastrand crosslinks are most commonly removed by the
nucleotide excision repair (NER) pathway, which involves
recognition of the crosslink and excision of the affected
strand [de Laat et al., 1999]. The DNA helix is restored
after the excised strand is replaced via repair synthesis
using the complimentary strand as a template, which is
followed by DNA ligation. Alternatively, intrastrand
crosslinks can be bypassed during replication by special-
ized DNA polymerases referred to as translesion DNA
polymerases, making these lesions relatively less toxic to
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proliferating cells. ICLs cannot be repaired by this robust
NER pathway alone or bypassed during replication due to
the fact that both strands of the double helix are involved
in a covalent linkage. Furthermore, excising the lesion
present on both strands simultaneously will result in re-
moval of the genetic information necessary for repair syn-
thesis. Therefore, multiple DNA repair processes are
engaged to remove ICLs in a manner that preserves
genomic integrity.
ICL REPAIR: FROM SIMPLE TO COMPLEX
The first model of ICL repair was brought to light by
the influential studies performed by Cole et al. [1973,
1976] implicating the cooperation of both NER and ho-
mologous recombination (HR) during ICL repair in E.
coli. The NER endonuclease UvrABC recognizes an ICL
formed in DNA (e.g., photoactivated psoralen) and makes
incisions on each side of the ICL within the same strand
of DNA, essentially ‘‘unhooking’’ the ICL, such that the
excised ICL forms a large monoadduct still attached to
other strand. The excised region of the opposite strand is
further processed into a large gap by DNA PolI exonucle-
ase activity that then serves as a substrate for RecA-medi-
ated HR with an undamaged chromosome [Sinden and
Cole, 1978a,b; Cheng et al., 1988; Sladek et al., 1989;
Cheng et al., 1991]. If recombination is not possible (e.g.,
in a recA mutant), an alternative approach is to fill in the
gap opposite the unhooked crosslink by translesion DNA
synthesis (TLS) through the activity of a specialized poly-
merase (such as PolII, PolIV, or PolV in E. coli) [Berar-
dini et al., 1999; Tang et al., 2000; Goodman, 2002;
Friedberg et al., 2005]. However, this alternative pathway,
also referred to as recombination-independent ICL repair,
can be associated with an increased risk for mutagenesis
due to the potential for miscoding and the error-prone na-
ture of lesion bypass polymerases. After recombination or
lesion bypass, the unhooked crosslink or monoadduct is
ultimately removed through a second round of NER
repair, thus restoring the DNA helix to its original state.
The results from these early studies in bacteria serve as
the foundation for current models of ICL repair. The basic
scheme of unhooking the ICL and resolution of the
unhooked crosslink by recombination or TLS combined
with NER to remove the unhooked ICL after gap repair
appears to be conserved in yeast, Drosophila, Xenopus,
and vertebrates [McVey, 2010]. However, the levels of
regulation and the number of pathways recruited into the
process dramatically increase in complexity, depending
upon whether repair is occurring in the absence of repli-
cation (i.e., replication-independent ICL repair) or during
S phase (i.e., replication-coupled ICL repair). Important
differences between prokaryotes and eukaryotes are now
well characterized. First, in higher eukaryotes (e.g., verte-
brates), ICL repair appears to be completed primarily dur-
ing the S phase of the cell cycle as opposed to in the ab-
sence of DNA replication, such as in G1 [Akkari et al.,
2000; Niedernhofer et al., 2004; Rothfuss and Grompe,
2004]. Second, the only NER proteins that have been
strongly associated with promoting resistance to inter-
strand crosslinking agents are XPF and ERCC1 that to-
gether comprise a structure-specific endonuclease, sug-
gesting that XPF-ERCC1 has a specific role in removing
ICLs from DNA that is independent of its function in
NER [Jachymczyk et al., 1981; Hoy et al., 1985; Ander-
sson et al., 1996; De Silva et al., 2000; Clingen et al.,
2005; Zhang et al., 2007]. Third, both TLS and HR coop-
erate during the resolution of unhooked ICLs in a manner,
which requires DNA replication, rather than a competition
between the TLS and HR pathways to resolve gap
remaining after unhooking the crosslink as suggested by
the early work in prokaryotes. These added layers of com-
plexity necessitate the involvement of a higher-order com-
plex of proteins to recruit and regulate the multiple enzy-
matic activities involved in ICL repair. Proteins in this
complex are encoded by genes that when mutated cause
the rare disease Fanconi anemia (FA) characterized by
bone marrow failure, developmental deficiencies, and pre-
disposition to cancer [Niedernhofer, 2007; Kee and
D’Andrea, 2010; Deans and West, 2011].
Over the past decade, enormous progress has been made
in defining the various steps operating during replication-
coupled ICL repair [Muniandy et al., 2010]. The current
model of replication-coupled ICL repair now includes the
actions of multiple pathways including NER, HR, mis-
match repair, TLS, and structure specific endonucleases
that are regulated at multiple levels by the BRCA1 tumor
suppressor, the ataxia telangiectasia and Rad3-related
(ATR) protein kinase, and the FA pathway [Cantor and
Xie, 2010; Hlavin et al., 2010; Ho and Scharer, 2010; Kee
and D’Andrea, 2010; Shen and Li, 2010; Vasquez, 2010;
Wood, 2010; Sengerova et al., 2011]. Coordination of these
multiple pathways is vital for maintaining genome stability
throughout the process, in addition to determining relative
hypersensitivity or resistance to ICL generating chemother-
apeutic drugs. It is now well recognized that TLS, espe-
cially through the activities of REV1 and DNA polymerase
zeta (Polf), is necessary for both ICL repair pathways
operating throughout the cell cycle and is the primary sub-
ject of this review.
REV1AND POLf: DNA POLYMERASES THAT
PROMOTE MUTAGENESIS
In 1971, Lemontt [1971] performed a screen for
mutants conferring a ‘‘reversionless’’ phenotype in
Saccharomyces cerevisiae and identified two genes, Rev1
and Rev3, that were actively involved in UV-induced
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mutagenesis. A similar screening later led to the identifi-
cation of the Rev7 gene [Lawrence et al., 1985]. Rev7
was later shown to form a heterodimeric complex with
Rev3 forming the accessory and catalytic subunits of
what is now referred to as Polf [Nelson et al., 1996b].
Rev1-deleted yeast cells show similar phenotypes to those
lacking Rev3 or Rev7, suggesting that Rev1 is necessary
for Polf-dependent mutagenesis. Thus, the genetic epista-
sis observed between Rev1, Rev3, and Rev7 in yeast con-
tributed to the prevailing model that Rev1 and Polf coop-
erate to perform lesion bypass and are considered the
main players participating in an error-prone pathway of
postreplication repair [Chang and Cimprich, 2009; Waters
et al., 2009]. It is important to note here that Rev1 and
Polf-dependent TLS not only occurs during replication,
but also after DNA replication has completed, being re-
sponsible for filling in gaps left behind after stalled repli-
cation forks resume replication downstream of a replica-
tion-blocking lesion; hence the term ‘‘postreplication
repair’’ was created to describe this process [Lopes et al.,
2006; Jansen et al., 2009a,b; Diamant et al., 2012]. The
fact that single-stranded DNA gaps created after replica-
tion fork stalling can persist in cells well into the G2
phase of the cell cycle suggests that mechanisms exist to
restart replication downstream of a blocking lesion. How
this ‘‘repriming’’ process is regulated remains largely
unclear.
REV3 belongs to the B-family of polymerases that
includes the highly accurate replicative DNA polymerases
including Pold, Pole, and Pola [Morrison et al., 1989;
Lawrence, 2004]. Polf possesses lower processivity and a
higher fidelity than the Y-family of TLS polymerases,
even though REV3 is devoid of the 30 ? 50 proofreading
exonuclease activity present in most B-family DNA poly-
merases [Morrison et al., 1989; Nelson et al., 1996b;
Lawrence, 2004]. Previous studies indicate that Polf is
not efficient in replicating through most DNA lesions and
can perform bypass only at certain lesions such as cis–syn
TT dimers where it has been reported to perform both the
insertion and extension steps opposite a thymine glycol
lesion in an error-free manner [Nelson et al., 1996b; John-
son et al., 2003]. Rather than inserting nucleotides oppo-
site DNA adducts, Polf appears to be particularly special-
ized to extend distorted base pairs, such as mismatches
that might result from an inaccurate base insertion by a
TLS polymerase or a base pair involving a bulky DNA
lesion [Lawrence, 2004; Prakash et al., 2005]. Therefore,
the primary role of Polf in TLS is proposed to be per-
forming an extension reaction from nucleotides inserted
opposite the lesion by another TLS polymerase [Prakash
and Prakash, 2002; Prakash et al., 2005]. This proficiency
in extending through mismatches along with a relatively
high-error rate for base substitutions is associated with the
mutagenic properties of Polf [Lawrence, 2004; Zhong
et al., 2006]. Although, Rev3 alone is capable of polymer-
ization, association of Rev3 with Rev7, the accessory sub-
unit of Polf, has been shown to stabilize and significantly
enhance the polymerase activity of Rev3 by 20–30-fold,
suggesting that Rev7 functions as a processivity factor for
Polf [Nelson et al., 1996b].
Yeast Rev1 was the first member of the Y-family pro-
teins characterized as a deoxycytidyl (dCMP) tansferase
rather than a processive DNA polymerase, whose activity
appears to be restricted to inserting dCMPs opposite gua-
nines and abasic sites in template DNA [Nelson et al.,
1996a]. Additional insights made from the crystal struc-
ture of the polymerase domain of S. cerevisiae Rev1
bound to a primer template, and an incoming dCTP
revealed that Rev1 uses a novel catalysis mechanism,
whereby the incoming dCTP pairs with an arginine rather
than a template base, and the template guanine is evicted
from the DNA helix [Nair et al., 2005]. This limited ac-
tivity does not seem to be important for most functions of
Rev1, because catalytic inactive Rev1 can still promote
Rev3-dependent mutagenesis in yeast [Nelson et al.,
2000; Lawrence, 2002]. Instead, Rev1 appears to play a
more important role in regulating Polf-dependent TLS.
The primary regulator of TLS in both E. coli and yeast
is the sliding clamp that functions to promote processivity
of DNA polymerases during replication [Friedberg et al.,
2005]. In E. coli, the homodimer, PolIII-associated sliding
b clamp (encoded by the dnaN gene) plays a central role
in mediating the switch from normal DNA replication to
TLS [Fujii and Fuchs, 2004]. In eukaryotes, the homotri-
meric-sliding clamp, proliferating cell nuclear antigen
(PCNA), plays a similar role in mediating the switch
between replication and TLS with an added level of regu-
lation, whereby TLS is activated by monoubiquitination
of PCNA [Hoege et al., 2002]. In S. cerevisiae, genetic
studies have shown that genes belonging to the Rad6
epistasis group are involved in the replication of damaged
DNA, a process referred to as postreplication repair
[Jentsch et al., 1987; Bailly et al., 1997; Broomfield
et al., 1998]. Of these, Rad6 and Rad18 are required for
both error-free and error-prone replication bypass of UV-
induced DNA lesions, while Rad5, Mms2, and Ubc13
play a role in regulating the replication past DNA adducts
in an error-free manner using a TLS polymerase-inde-
pendent mechanism [Xiao et al., 2000]. Rad6 and the
Mms2-Ubc13 complex function as E2 ubiquitin-conjugat-
ing enzymes in association with the Rad18 and Rad5 E3
ubiquitin ligases, respectively, and regulate the ubiquitina-
tion state of PCNA [Jentsch et al., 1987; Bailly et al.,
1997; Hoege et al., 2002].
In response to replication fork stalling and the genera-
tion of long stretches of single-stranded DNA, Rad6 and
Rad18 monoubiquitinate PCNA on lysine-164 (K164)
triggering postreplication repair [Davies et al., 2008]. One
potential outcome is mutagenic lesion bypass by Rev1
and Polf. Alternatively, the other TLS polymerase
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expressed in yeast, Polh (encoded by the Rad30 gene)
can accurately insert nucleotides opposite thymine
dimers, thus preventing UV-induced mutatagenesis. The
ubiquitin conjugated to PCNA on K164 can be further
extended forming a K63-linked ubiquitin chain attached
to PCNA in a reaction mediated by Mms2–Ubc13 and
Rad5 [Hofmann and Pickart, 1999; Hoege et al., 2002;
Andersen et al., 2008]. Although the monoubiquitination
of PCNA mediates the switch to TLS, evidence suggests
that polyubiquitination of PCNA channels postreplication
repair into an uncharacterized error-free damage avoid-
ance pathway that involves template switching [Stelter
and Ulrich, 2003].
All eukaryotic Y-family polymerases including REV1
possess ubiquitin-binding motifs (UBM) or ubiquitin-bind-
ing zinc finger (UBZ) domains that increase their affinity
for ubiquitinated PCNA [Kannouche et al., 2004; Wata-
nabe et al., 2004; Bienko et al., 2005; Plosky et al., 2006;
Acharya et al., 2008; Sabbioneda et al., 2008; Bomar
et al., 2010]. Although the ubiquitination of PCNA is nec-
essary for TLS in yeast, recent studies suggest that alter-
native pathways may regulate polymerase switching in
vertebrates. Analysis of the replication of damaged DNA
in chicken DT40 cells demonstrated a predominant role
for PCNA ubiquitination in promoting the filling in of
postreplication gaps [Edmunds et al., 2008]. However,
REV1-dependent TLS across a TT 6-4 photoproduct (a
dominant UV lesion) in DT40 cells carrying a PCNA
K164 mutation appears to be normal as measured by a
plasmid system [Szüts et al., 2008]. Recent work from the
Livneh group used mouse embryonic fibroblasts in which
specific TLS genes associated with ubiquitination of
PCNA were manipulated. These studies showed that elim-
inating expression of REV3, Polh, or REV1 in
PCNAK164R/K164R mouse embryo fibroblasts further
increased their sensitivity to UV-radiation indicating the
existence of a TLS pathway that is independent of PCNA
ubiquitination [Hendel et al., 2011]. At least in DT40
cells, this noncanonical TLS pathway appears to be
largely dependent on REV1 [Edmunds et al., 2008; Szüts
et al., 2008]. Recent studies identified the FA core com-
plex as being an important regulator of REV1 localization
to stalled replication forks resulting from UV or cisplatin
treatment [Mirchandani et al., 2008; Hicks et al., 2010;
Kim et al., 2012].
REV1AND POLf: COLLABORATORS IN COMPLETING TLS
ACROSSMANYDNA LESIONS
As discussed earlier, REV1 contains two UBMs that
are important for recruitment to blocked DNA replication
forks or gaps remaining in DNA after the completion of
replication [Bienko et al., 2005; Guo et al., 2006]. REV1
also possesses a unique polymerase interacting domain
that makes direct contact with REV7 and a variety of
TLS DNA polymerases including Polh and REV3 [Mura-
kumo et al., 2001; Guo et al., 2003; Masuda et al., 2003;
Ohashi et al., 2004; Tissier et al., 2004; Acharya et al.,
2006; D’Souza and Walker, 2006]. Today, it has become
clear that for most DNA adducts, more than one TLS po-
lymerase is needed to accomplish a single lesion bypass
event in cells [Shachar et al., 2009; Hicks et al., 2010].
Current models suggest a two-step process where a Y
family polymerase inserts the first nucleotide opposite a
damaged base, and a second polymerase performs the
extension step, even if the resulting primer/template pair
is highly distorted [Prakash and Prakash, 2002]. Polf is
thought to be the ‘‘universal extender’’ due to its ability
to extend a wide variety of distorted or mismatched
primer templates [Johnson et al., 2000b; Haracska et al.,
2001]. REV1 is thought to primarily be a regulator of
TLS by orchestrating polymerase switching events
between the first TLS polymerase and the universal ex-
tender, Polf [Guo et al., 2003; Acharya et al., 2006]. This
dependence of Polf on REV1 is consistent with the fact
that Polf lacks a UBD to preferentially localize to regions
where PCNA has been monoubiquitinated by the RAD18
ubiquitin ligase.
Until recently, very little was known about how mam-
malian REV1 interacts with Polf and other Y-family TLS
polymerases. Earlier studies have characterized potential
binding sites between REV1, REV3, and REV7 using
yeast two hybrid assays and coimmunoprecipitation analy-
ses, but it remained unclear whether these three proteins
form a heterotrimer in cells [Murakumo et al., 2000; Mur-
akumo et al., 2001; Guo et al., 2003; Ohashi et al., 2004].
We found that REV1 is capable of coimmunoprecipitating
with REV3 in REV7-depleted cells, suggesting that full-
length REV3 and REV1 have an additional mode of inter-
action yet to be identified [Sharma et al., 2012a]. Based
on the recent crystal structure between REV7 and the
REV7-binding site in REV3 (amino acids 1847-1898)
[Hara et al., 2010], Hara et al. suggest that REV7 binds
both REV3 and REV1 simultaneously where binding of
REV7 to REV3 alters the conformation of REV7 in a
way that reveals an additional REV1-binding site. This is
an intriguing result, because it has always been assumed
that REV7 interactions with REV1 and REV3 were mutu-
ally exclusive. In fact, recent structural and biochemical
studies now indicate that the C-terminal domain of REV1
can simultaneously interact with REV7 as well as the
REV1-interacting region of other Y family polymerases
(like Polh and Polj) [Kikuchi et al., 2012, in press; Poz-
hidaeva et al., 2012; Wojtaszek et al., 2012, in press].
These studies provide clues about the possible role of the
REV1 C-terminal domain in facilitating TLS polymerase
switching by demonstrating that REV1 does in fact pro-
vide a scaffold for both inserter (e.g. Polh) and extender
polymerases (Polf) to bind during the replicative bypass
Environmental and Molecular Mutagenesis. DOI 10.1002/em
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of complicated lesions [Kikuchi et al., 2012, in press].
Future studies will be needed to fully disclose how REV1
performs its function as a TLS polymerase ‘‘switcher’’
during complex lesion bypass events. Figure 1 illustrates
the various domains within REV3, REV1, and REV7
(MAD2L2) that have been characterized to date.
REV1AND POLf: ESSENTIAL FOR TLS DURING ICL REPAIR
The specialized function of REV1 and Polf in ICL
repair came to light when the extreme sensitivities to
agents capable of forming ICLs were noted in eukaryotic
cells lacking either one of these two polymerases
[Simpson and Sale, 2003; Sonoda et al., 2003; Niedz-
wiedz et al., 2004; Wu et al., 2004; Zander and Bemark,
2004; Nojima et al., 2005; Okada et al., 2005; Cheung
et al., 2006; Lin et al., 2006; Sarkar et al., 2006; Witt-
schieben et al., 2006; Roos et al., 2009; Wang et al.,
2009; Hicks et al., 2010; Sharma et al., 2012b]. In com-
parison, the sensitivities of cells lacking REV1 or Polf to
agents that create primarily monoadducts in DNA are rel-
atively benign, suggesting that REV1 and Polf play a spe-
cialized role in ICL repair.
In yeast, the importance of ICL repair during the G1
phase or in stationary phase is well documented. ICL
repair in G1 is initiated following the recognition and
unhooking of the ICL by the NER pathway in an analo-
gous fashion as first described in bacteria. The TLS path-
way became implicated following the observations that
ICLs are highly mutagenic and mutations in Rev3 (Pso1)
or Rad6 (Pso8), the E2 ubiquitin-conjugating enzyme
associated with Rad18 during postreplication repair, are
associated with hypersensitivities to psoralen ICLs [Henri-
ques and Moustacchi, 1980; Cassier and Moustacchi,
1981; Henriques and Moustacchi, 1981; Barre et al.,
1999; De Silva et al., 2000]. The replication-independent
model was then studied in greater detail revealing that
yeast Rev3 mutants are specifically hypersensitive to ICL-
generating agents in G1 [McHugh et al., 2000; Sarkar
et al., 2006]. Genetic and biochemical evidence suggest
that following unhooking of an ICL by the NER machin-
ery, normal replicative polymerases such as Pold attempt
to fill in the gap opposite the adduct but stall, initiating
the Rad18-dependent PCNA ubiquitination pathway that
directs Rev1 and Polf to perform TLS. Consistent with
the findings by others, Polf-dependent TLS requires the
yeast Pold subunit Pol32, and in the case for ICL repair,
Pol32 is required for PCNA ubiquitination and Rev7
recruitment to chromatin in an ICL-dependent manner
[Huang et al., 2000; Gibbs et al., 2005; Sarkar et al.,
2006; Acharya et al., 2009]. Whether a similar pathway
operates in vertebrates to repair ICLs in G1 is unknown.
However, reporter assays designed to measure recombina-
tion-independent ICL repair in vertebrates do strongly
suggest that NER endonuclease XPF-ERCC1, Polf, and
RAD18 cooperate to repair ICLs in a manner that does
not require DNA replication, at least in an extrachromoso-
mal context [Wang et al., 2001; Shen et al., 2006]. In
intact cells, the global genome NER protein XPC is rap-
idly recruited to psoralen ICLs in G1 cells, and their re-
moval was defective in XPC-deficient cells [Muniandy
et al., 2009]. Schärer’s group has recently implicated the
transcription-coupled NER protein CSB, as well as the
general NER proteins XPA, XPF, and XPG, in the repair
of cisplatin ICLs independently of DNA replication
[Enoiu et al., in press]. Similar to yeast, REV1 and Polf
are crucial for this repair pathway executed during the G1
phase of the cell cycle. The initial recognition of the ICL
involves either the transcription-coupled or global genome
NER pathway depending upon the lesion present (Fig. 2).
The link between DNA replication, HR, and ICL repair
was established with the findings that ICL-generating
agents cause DNA double-stranded breaks (DSBs) in a
Environmental and Molecular Mutagenesis. DOI 10.1002/em
Fig. 1. Physical representation of the functional domains of the human
REV3, REV1, and REV7 proteins. REV3 has a region in the N-terminus
that is homologous to Pold, a REV7-binding domain, and a conserved
Zinc finger motif in the catalytic domain. REV1 possesses a BRCT do-
main that interacts with PCNA or DNA, two ubiquitin-binding motifs
that mediate localization to stalled replication forks, and a C-terminal
TLS polymerase and REV7-binding domain. REV7 is almost entirely
composed of a HORMA domain that is thought to mediate interactions
with chromatin. [Color figure can be viewed in the online issue, which
is available at wileyonlinelibrary.com.]
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manner dependent upon DNA replication, and cells defi-
cient in HR repair are extremely sensitive to these agents
[Muniandy et al., 2010]. Based on these observations,
models explaining ICL repair in mammals evolved to
include unhooking, which can occur in the G1 or S
phases of the cell cycle, and collision of the DNA replica-
tion machinery on the processed ICL. The unhooked
lesion causes replication fork stalling and release of one
arm of the replication fork to generate a ‘‘one-ended’’
DSB. Repair of this replication-associated DSB is chan-
neled into the HR repair pathway [McHugh et al., 2001;
Hinz, 2010; Deans and West, 2011]. Earlier studies moni-
toring the generation of DSBs in cells following treatment
with mitomycin C using g-H2AX as a surrogate marker
for DSBs, as well as pulsed-field gel electrophoresis, first
implicated the structure-specific MUS81-EME1 endonu-
clease as being required for DSB generation in S phase
[Hanada et al., 2006]. Multiple endonucleases, including
XPF-ERCC1, SLX4, FAN1, and SNM1A, are also
thought to play important roles in the initial lesion
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Fig. 2. Models for human ICL repair. Nonproliferating cells are capa-
ble of removing ICLs in a manner that is independent of DNA replica-
tion. Depending upon the type of ICL or whether the ICL has inter-
fered with RNA transcription, the XPC/HR23B (global genome NER)
or CSB (transcription-coupled NER) protein recognizes the lesion and
stimulates ‘‘unhooking’’ by the XPF-ERCC1 endonuclease. A single-
stranded DNA gap is formed that attracts replication protein A (RPA),
which in turn promotes RAD18/RAD6-dependent monoubiquitination of
PCNA. Monoubiquitinated PCNA recruits REV1/Polf and/or Polj to
the site where they perform TLS opposite the unhooked lesion, the lat-
ter presumably removed by a second set of NER events to return the
DNA duplex to its original state. If the lesion is not removed in G1
(left panel), convergence of DNA polymerases on an unrepaired ICL
during DNA replication initiates the Fanconi anemia (FA) pathway
involving detection of the ICL by the FA core complex followed by
ubiquitination of the FANCD2/FANCI heterodimer in the late S/G2
phase of the cell cycle (right panel). Ubiquitinated FANCD2/FANCDI
promotes excision or ‘‘unhooking’’ of the ICL by structure-dependent
endonucleases and likely promotes TLS opposite the ‘‘unhooked’’ ICL
in preparation for homologous recombination (HR). MUS81-EME1,
SNM1A, FAN1, XPF-ERCC1, and SLX1-SLX4 are structure-specific
endonucleases thought to be involved in unhooking the ICL, generating
ICL-associated double-strand breaks (DSBs) and nucleolytic processing
of the ICL during repair. SLX4 has also been shown to be an endonu-
clease scaffold protein and mutations in the SLX4 gene cause FA.
FAAP20 interacts with the FA core complex and directly binds to
REV1. The mismatch repair protein MSH2 is implicated in ICL repair
through an unknown mechanism. The FA pathway and REV1/Polf can
promote HR repair of a direct DSB. We speculate that REV1 and Polf
are not only involved in TLS across the ‘‘unhooked ICL’’ but also per-
form DNA synthesis during HR repair when the template is incompati-
ble for normal replicative DNA polymerases.
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processing events required for ICL repair [Fekairi et al.,
2009; Muñoz et al., 2009; Svendsen et al., 2009; Kratz
et al., 2010; Liu et al., 2010; MacKay et al., 2010; Smo-
gorzewska et al., 2010; Yang et al., 2010; Kim et al.,
2011; Stoepker et al., 2011; Wang et al., 2011; Yama-
moto et al., 2011]. Together, these studies strongly sug-
gest that the generation of DSBs in cells treated with ICL
generating agents is an active process and not caused by
regression of a stalled fork resulting in collapse. After
incision and DSB formation upon collision of a replica-
tion fork with an ICL, multiple factors are involved in the
completion of repair, including REV1 and Polf, the FA
pathway, the mismatch repair MSH2 protein, XPF-
ERCC1, and HR repair [Zhang et al., 2007]. A common
phenotype in cells deficient in any of these proteins or
pathways is an inability to resolve ICL-induced DSBs in
a timely manner [Rothfuss and Grompe, 2004; Hicks
et al., 2010; Kratz et al., 2010; Liu et al., 2010; MacKay
et al., 2010; Wang et al., 2011].
Additional studies performed in mammalian cells sup-
port the model that REV1 and Polf perform an essential
step that allows ICL-associated DSBs to be channeled
into the HR repair pathway. Human cancer cells depleted
of REV1, REV3, or REV7 are significantly more sensitive
to cisplatin or mitomycin C when compared with those
depleted of RAD18 or Polh [Hicks et al., 2010]. This
hypersensitivity correlates with a defect in the resolution
of replication-associated DSBs and the accumulation of
chromosomal aberrations following drug treatment. These
deficiencies in resolving ICL-associated DSBs and pre-
venting clastogenic effects associated with interstrand
crosslinking agents were very similar to cells lacking
RAD51, which is essential for HR repair, or the many
other factors associated with ICL repair. Although PCNA
monoubiquitination by RAD18 is important for the local-
ization of both Polh and REV1 to facilitate bypass of cis-
platin intrastrand crosslinks, the absence of RAD18 failed
to duplicate the deficiencies in ICL observed in cells lack-
ing REV1 or Polf, suggesting an alternative mechanism
exists that promotes TLS during ICL repair, at least in the
cancer lines examined [Hicks et al., 2010]. It is important
to note here that agents that cause nondistorting ICLs
(e.g., mitomycin C) or create DSBs in DNA (ionizing
radiation or topoisomerase poisons) are not potent
inducers of PCNA monoubiquitination per se [Shiomi
et al., 2007; Niimi et al., 2008; Brown et al., 2009; Hicks
et al., 2010]. However, RAD18 may play additional roles
in regulating the FA pathway and ICL repair by facilitat-
ing the activation of the FA FANCD2/FANCI hetero-
dimer [Geng et al., 2010; Song et al., 2010; Palle and
Vaziri, 2011; Williams et al., 2011].
Xenopus laevis extracts have been an extraordinary use-
ful system for studying the biochemistry of DNA replica-
tion, and, recently, ICL repair of a single cisplatin ICL
placed in a plasmid capable of undergoing replication.
The landmark work by Walter and coworkers [2008] pro-
vided unequivocal evidence that Polf (as inferred by
immunodepletion of Rev7) plays a crucial role in per-
forming TLS across an unhooked crosslink after conver-
gence of two replication forks upon the ICL. The model
proposed from these studies involves incision of the ICL
on both sides of the sister chromatid generating a two-
ended DSB, which is unique from previous models, sug-
gesting the generation of a one-ended DSB. In order for
HR repair to proceed, the collaborative actions of Rev1
and Polf are needed to insert a nucleotide opposite the
unhooked ICL followed by extension to restore the other
sister chromatid. Interestingly, recent biochemical studies
have characterized Polf as being inefficient at mediating
TLS across artificial ‘‘unhooked’’ crosslinks in vitro [Ho
et al., 2011].
THE FA PATHWAY: REGULATOROF REV1AND POLf?
At least 16 FA or FA-interacting genes have been iden-
tified, and these ‘‘FA’’ proteins have been shown to form
several complexes to orchestrate ICL repair [Moldovan
and D’Andrea, 2009; Deans and West, 2011; Kim et al.,
2012]. Eight of these proteins (FANCA, -B, -C, -E, -F, -
G, -L, and -M) along with five FA-associated proteins
(FAAP100, FAAP24, HES1, MHF1, MHF2, and the
newly identified FAAP20) form the nuclear core complex
[Gurtan and D’Andrea, 2006; Huang et al., 2010; Kee
and D’Andrea, 2010; Ali et al., 2012; Constantinou, 2012;
Kim et al., 2012; Leung et al., 2012]. The core complex
functions as an E3 ubiquitin ligase by monoubiquitinating
the FANCD2-FANCI heterodimer in response to DNA
damage [Garcia-Higuera et al., 2001; Dorsman et al.,
2007; Sims et al., 2007; Smogorzewska et al., 2007].
Monoubiquitination takes place constitutively in the S-
phase and is dramatically increased upon DNA damage
[Garcia-Higuera et al., 2001; Taniguchi et al., 2002].
Upon damage, the monoubiquitinated FANCD2-I complex
is then recruited to the chromatin where it interacts with
downstream FA proteins [FANCD1/BRCA2, FANCJ/
BACH1, FANCN/PALB2, FANCO/RAD51C, and
FANCP/SLX4 along with the FA-associated nuclease 1
(FAN1)] that are all involved in promoting HR repair
[Howlett et al., 2002; Litman et al., 2005; Reid et al.,
2007; Xia et al., 2007; Shen et al., 2009; Liu et al., 2010;
Smogorzewska et al., 2010; Vaz et al., 2010; Crossan
et al., 2011; Stoepker et al., 2011]. Monoubiquitinated
FANCD2 also provides binding sites for SLX4 and
FAN1, which are structure-specific endonucleases, that
play roles in unhooking the ICL, HR repair, and poten-
tially facilitating TLS [Liu et al., 2010; Cybulski and
Howlett, 2011; Sengerova et al., 2011; Yamamoto et al.,
2011]. Deficiencies in any of these proteins result in
the characteristic deficiency in DSB resolution following
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exposure to DNA crosslinking agents, as well as reduc-
tions in gene conversion efficiencies, identical to what has
been observed in REV1 or Polf-depleted cells [Hicks
et al., 2010; Sharma et al., 2012a].
Patel and coworkers [2004] first demonstrated the epi-
static relationship between the FANCC gene, which enco-
des one of the FA core proteins, and REV1 or REV3 in
chicken DT40 cells treated with cisplatin thus directly
implicating REV1 and REV3 in ICL repair. The authors
found little difference in the sensitivities of FANCC2/2
DT40 cells compared to FANCC2/2 REV12/2 cells or
FANCC2/2 REV32/2 cells to loss in viability or the
accumulation of chromosomal aberrations following cis-
platin treatment, thus establishing an epistatic relationship
between these genes. Sonoda and coworkers’ [2005] labo-
ratory confirmed these observations. The direct evidence
regarding the involvement of the FA pathway in ICL
repair was once again obtained using the Xenopus leavis
egg extract system, wherein it was shown that FANCD2-
FANCI ubiquitination promotes the incision and TLS
steps of ICL repair [Knipscheer et al., 2009]. This work
led to the proposal that like PCNA ubiquitination,
FANCD2-I ubiquitination plays a role in recruiting TLS
polymerases to ICLs via their UBM/UBZ domains. Also,
a direct interaction between the putative PIP domain of
FANCD2 and PCNA has been demonstrated [Howlett
et al., 2009]. However, to date, no evidence exists that
suggest a direct interaction between FANCD2 and REV1.
Regardless, these studies brought forth the most current
model for ICL repair that involves the cooperation
between the FA pathway and translesion DNA synthesis
by REV1, Polf, and HR.
The hallmark of FA patient cells, as well as cells defi-
cient in the breast cancer and HR repair associated-pro-
teins BRCA1 or BRCA2, or the TLS polymerases REV1
and Polf, is hypersensitivity to the clastogenic effects of
DNA interstrand crosslinking agents such as cisplatin and
mitomycin C [Garcia-Higuera et al., 2001; Howlett et al.,
2002; Venkitaraman, 2004]. The formation of aberrant ra-
dial chromosomes in patient cells treated with DNA
crosslinking agents is a common diagnostic test for FA,
and these specific aberrations have been identified in
REV1-depleted mammalian cells [Mirchandani et al.,
2008; Auerbach, 2009]. Given the fact that the formation
of radial chromosomes has not been identified in cells de-
ficient in other TLS polymerases treated with ICL-gener-
ating agents, the exception being DNA polymerase nu
and kappa [Minko et al., 2008; Moldovan et al., 2010]
underscores the importance of REV1 and Polf in ICL
repair.
Recent work from the D’Andrea and coworkers [2012]
identified a novel FA core component—FAAP20—which
directly binds to FANCA, while the C-terminal UBZ4 do-
main of FAAP20 directly binds to REV1, thereby provid-
ing a functional link between the two pathways. Although
these studies suggest that FAAP20 specifically promotes
REV1-dependent TLS across replication stalling lesions
like UV-induced thymine dimers, FAAP20 also plays an
important role in facilitating ICL repair by facilitating
FANCD2/FANCI monoubiquitination and activation of
the ICL repair pathway [Ali et al., 2012; Leung et al.,
2012; Yan et al., 2012]. These studies support the idea
that FAAP20 may directly promote REV1-dependent TLS
during ICL repair. A model for mammalian ICL repair
during DNA replication is presented in Figure 2 (left
panel).
DO REV1AND POLf ACTALONE DURING ICL REPAIR?
DNA Polymerase Kappa
DNA polymerase kappa (Polj), a homologue of the E.
coli DinB (DNA Pol IV) gene found in higher eukaryotes,
belongs to the Y-family of DNA polymerases [Ogi et al.,
1999; Johnson et al., 2000a; Gerlach et al., 2001; Ohmori
et al., 2001]. Polj is known to be involved in error-free
bypass of bulky minor groove N2-deoxyguanine adducts
and plays a critical role in limiting mutagenesis from
these lesions [Ogi et al., 2002; Zhang et al., 2002; Avkin
et al., 2004; Choi et al., 2006; Jarosz et al., 2006; Temvir-
iyanukul et al., 2012]. Polj has also been shown to pro-
cess N2–N2 guanine minor groove ICLs, and the effi-
ciency of this bypass increases with the shortening of
nontemplate-crosslinked strand [Minko et al., 2008]. It
has also been demonstrated in vitro that error-free bypass
of a model acrolein-mediated N2-dG ICL involves the si-
multaneous action of two polymerases, wherein REV1
contributes to the bypass by inserting dC opposite the
cross-linked dG while primer extension is performed by
Polj [Klug et al., 2012]. Supporting a role in ICL repair,
siRNA-mediated depletion of Polj in GM639 cells led to
increased hypersensitivity and increased chromosomal
damage in the form of radial formation upon treatment
with MMC [Minko et al., 2008], a characteristic pheno-
type of FA patient cells. On the other hand, Polj-deficient
chicken DT40 cells display similar sensitivity to cisplatin
as the wild-type cells [Nojima et al., 2005]. Recently, a
role for Polj in performing replication-independent repair
of a helix-distorting trimethylene ICL has been described
in Xenopus egg extracts, and efficient repair can be meas-
ured in the absence of Polf [Williams et al., 2012]. As
previously mentioned, replication-independent repair of a
cisplatin ICL in mammalian cells requires REV1 and
Polf, whereas Polj-deficient cells show a minor defect in
the repair of this specific lesion [Enoiu et al., in press].
Additional studies are needed to understand whether these
differences in results can be explained by the type of ICL
lesion being repaired or the cellular context (or model
system) being examined, or whether Polj collaborates
with REV1 and Polf during ICL repair in resting cells.
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DNA Polymerase Theta and Nu
Genetic studies performed in Drosopila melanogaster
identified the mus308 gene as playing an important role
in the resistance to DNA crosslinking agents such as
nitrogen mustards and cisplatin [Boyd et al., 1981, 1990].
Mus308 is composed of both an N-terminal helicase-like
domain and a C-terminal A-family polymerase domain
[Harris et al., 1996; Oshige et al., 1999; Pang et al.,
2005]. Poly is the closest relative of mus308 in verte-
brates and possesses both the C-terminal A-family DNA
polymerase domain and the N-terminal helicase-like do-
main [Sharief et al., 1999; Seki et al., 2003]. POLy is a
low-fidelity DNA polymerase capable of efficient bypass
of abasic sites and thymine glycols as well as extension
of mismatched primer termini [Seki et al., 2004; Arana
et al., 2008; Seki and Wood, 2008; Hogg et al., 2011;
Hogg et al., 2012]. Experiments in avian DT40 cells have
shown that the deletion of POLy alone or in combination
POLN or HEL308 does not convey hypersensitivity to
DNA crosslinking agents [Yoshimura et al., 2006]. How-
ever, POLy-deficient cells display spontaneous radiation
and mitomycin C-induced chromosomal abnormalities
implicating a possible role of POLy in ICL or HR repair
[Shima et al., 2003, 2004; Goff et al., 2009]. Studies in
Caenorhabditis elegans have also identified a role for
POLQ-1 (a POLy homolog) in ICL repair [Muzzini et al.,
2008]. In addition to a role in ICL repair, POLy also pro-
motes base-excision repair of oxidative damage [Yoshi-
mura et al., 2006] and somatic hypermutation [Masuda
et al., 2005, 2007; Seki et al., 2005; Martomo et al.,
2008; Kohzaki et al., 2010].
Polm (POLN) and HEL308 (HELQ) are smaller
Drosophila mus308 gene homologs in vertebrates and
separately make up the polymerase and the helicase-like
domain, respectively, of mus308. HEL308 displays 30 ?
50 helicase activity [Marini and Wood, 2002], whereas
POLm is a low-fidelity A-family DNA polymerase that
generates a high-error rate when incorporating nucleotides
opposite dG [Marini and Wood, 2002; Marini et al.,
2003]. Polm is capable of DNA-templated synthesis and
can bypass thymine glycols, a product of oxidative stress,
with a high-fidelity in vitro [Takata et al., 2006]. A recent
report showed that Polm can also perform efficient bypass
of major groove ICLs with the linkage between N6-dAs in
complementary DNA strands. On the other hand, Polm
was blocked when the lesions were located in the minor
groove via a N2-dG linkage, thus implying that the ability
of Polm to bypass ICLs is structure-dependent [Yamanaka
et al., 2010]. In vitro experiments also show that purified
Polm conducts low-efficiency nonmutagenic bypass of
psoralen ICLs [Zietlow et al., 2009].
The most convincing evidence, suggesting an important
role for Polm in ICL repair, was obtained analyzing the
effects of Polm-depleted in human cells. HeLa cells defi-
cient in Polm display increased sensitivity to MMC and
cisplatin [Zietlow et al., 2009; Moldovan et al., 2010].
Furthermore, D’Andrea and coworkers [2010] identified
HEL308 as a Polm-interacting protein and demonstrated
that both these proteins share an epistatic relationship
with FANCD2 strongly, suggesting that these proteins
cooperate to promote ICL and HR repair. Similar to
POLm, HEL308 also plays a role in ICL repair in C. ele-
gans [Muzzini et al., 2008]. However, like POLy, DT40
cells lacking POLm do not display hypersensitivity to cis-
platin or mitomycin C treatment [Yoshimura et al., 2006].
These results indicate that important differences exist
between DT40 and human cells in the roles TLS polymer-
ases play in promoting genomic stability, underscoring
the importance of studying these pathways in both model
systems.
TRANSLESIONDNA SYNTHESIS: PREPARINGTHE
TEMPLATE FOR HR REPAIROR PARTICIPATING IN HR
REPAIR
The identification of BRCA2 and RAD51C mutations
causing FA-like syndromes provided a direct link between
the FA pathway and regulation of homologous recombina-
tion (HR) repair [Howlett et al., 2002; Vaz et al., 2010].
Other members of the FA pathway have also been impli-
cated in regulating or participating in HR repair [Niedz-
wiedz et al., 2004; Nakanishi et al., 2005; Yamamoto
et al., 2005; Smogorzewska et al., 2007; Zhang et al.,
2007; Kratz et al., 2010; Pace et al., 2010]. Deficiencies
in the FA pathway are typically associated with partial
defects in HR repair, the exception being BRCA2 defi-
ciency, because this protein is essential for RAD51 load-
ing. We have also discovered that depletion of REV1,
REV3, or REV7 is associated with a reduction in HR effi-
ciency by 50%, similar to FA cells, as opposed to 90–
95% seen in cells deficient in the RAD51 protein [Sharma
et al., 2012a]. This same reduction in HR repair is
observed in cells depleted of Polm or HEL308, and no
additive reductions in gene conversion efficiencies are
observed when FANCD2 codepleted along with Polm,
suggesting that Polm participates in the FA pathway regu-
lating HR repair [Moldovan et al., 2010]. Because these
studies are measuring repair of a site-specific DSB by
HR, they imply that alternative DNA polymerases may be
needed to perform a subset of these reactions and are not
specifically confined to preparing the sister chromatid for
HR repair after ICL unhooking. This idea has been
recently confirmed in genetic studies using Drosophila
melanogaster as a model system, demonstrating a specific
requirement for Polf during HR repair [Kane et al.,
2012]. Together, these observations suggest that REV1
and Polf (possibly in collaboration with Polm) may be
required to synthesize DNA during a subset of HR reac-
tions that involve extension of distorted or mispaired
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primer templates that would otherwise cause stalling of
normal DNA polymerases. At least in mammalian cells,
the FA pathway may be important for regulating TLS
during HR repair.
CONCLUSION
Both REV1 and Polf have been implicated in promot-
ing DSB repair and genomic stability [Sonoda et al.,
2003; Okada et al., 2005; Wittschieben et al., 2006;
Schenten et al., 2009; Sharma et al., 2012a]. The results
from these studies at least partially explain why REV3 is
required for embryogenesis in mice, in addition to the
apparently nonredundant function of REV3 as a TLS po-
lymerase promoting replication across a multitude of
DNA lesions, including those associated with oxydative
stress [Bemark et al., 2000; Wittschieben et al., 2000;
Wang et al., 2002; Lange et al., 2012]. It is becoming
increasingly clear that Polf contributes to tumor suppres-
sion and is essential for the cell proliferation of non-
transformed mouse embryonic fibroblasts [Wittschieben
et al., 2010; Lange et al., 2012]. On the other hand, cul-
tured human cancer cell lines appear to be far more sen-
sitive to REV3 depletion compared to ‘‘normal’’ cells,
as measured by the increased formation of DSBs and
loss in clonogenic survival in the absence of treatment
with genotoxic agents [Knobel et al., 2011]. These are
intriguing observations in that they suggest that inhibi-
ting REV3 could be a viable approach to selectively kill-
ing tumor cells.
The importance of REV1 and Polf in promoting resist-
ance to DNA crosslinking agents has important clinical
implications. The emergence of drug resistance to cispla-
tin and cyclophosphamide is linked to the activities of
REV3 and REV1 in murine models of B-cell lymphoma
and lung adenocarcinoma [Doles, 2010; Xie et al., 2010].
Rendering tumor cells REV1 or REV3-deficient using
shRNA significantly sensitize these tumors to treatment
and limited the emergence of drug resistance, the latter
thought to be attributed to mutagenic bypass of DNA
crosslinks. Taken together, these data suggest that inhibi-
tion of REV1 or Polf may have dual anticancer effects—
sensitizing tumors to therapy and preventing the emer-
gence of chemoresistance by limiting drug-induced muta-
genesis. Before REV1 or Polf can be considered as tar-
gets alone or for adjuvant therapy with crosslinking
agents, the additional roles characterized for REV1 and
Polf in maintaining genomic stability will need to be bet-
ter understood.
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Ellenberger TE, Schärer OD, Walter JC. 2008. Mechanism of
replication-coupled DNA interstrand crosslink repair. Cell
134:969–980.
Reid S, Schindler D, Hanenberg H, Barker K, Hanks S, Kalb R, Nevel-
ing K, Kelly P, Seal S, Freund M, Wurm M, Batish SD, Lach
FP, Yetgin S, Neitzel H, Ariffin H, Tischkowitz M, Mathew CG,
Auerbach AD, Rahman N. 2007. Biallelic mutations in PALB2
cause Fanconi anemia subtype FA-N and predispose to childhood
cancer. Nat Genet 39:162–164.
Roos WP, Tsaalbi-Shtylik A, Tsaryk R, Güvercin F, de Wind N, Kaina
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